Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Yan Leyfman"'
Autor:
Yan Leyfman, Nancy Emmanuel, Gayathri P. Menon, Muskan Joshi, William B. Wilkerson, Jared Cappelli, Timothy K. Erick, Chandler H. Park, Pushpa Sharma
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-15 (2023)
Abstract Cancer patients, due to their immunocompromised status, are at an increased risk for severe SARS-CoV-2 infection. Since severe SARS-CoV-2 infection causes multiple organ damage through IL-6-mediated inflammation while stimulating hypoxia, an
Externí odkaz:
https://doaj.org/article/0c84d6029e0c4dd0a05bf9775a8ba0fe
Autor:
Stanislaw P Stawicki, Rebecca Jeanmonod, Andrew C Miller, Lorenzo Paladino, David F Gaieski, Anna Q Yaffee, Annelies De Wulf, Joydeep Grover, Thomas J Papadimos, Christina Bloem, Sagar C Galwankar, Vivek Chauhan, Michael S Firstenberg, Salvatore Di Somma, Donald Jeanmonod, Sona M Garg, Veronica Tucci, Harry L Anderson, Lateef Fatimah, Tamara J Worlton, Siddharth P Dubhashi, Krystal S Glaze, Sagar Sinha, Ijeoma Nnodim Opara, Vikas Yellapu, Dhanashree Kelkar, Ayman El-Menyar, Vimal Krishnan, S Venkataramanaiah, Yan Leyfman, Hassan Ali Saoud Al Thani, Prabath W B Nanayakkara, Sudip Nanda, Eric Cioè-Peña, Indrani Sardesai, Shruti Chandra, Aruna Munasinghe, Vibha Dutta, Silvana Teixeira Dal Ponte, Ricardo Izurieta, Juan A Asensio, Manish Garg
Publikováno v:
Journal of Global Infectious Diseases, Vol 12, Iss 2, Pp 47-93 (2020)
What started as a cluster of patients with a mysterious respiratory illness in Wuhan, China, in December 2019, was later determined to be coronavirus disease 2019 (COVID-19). The pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
Externí odkaz:
https://doaj.org/article/54dde6b83e8d488f9413e54451ed948c
Autor:
Yan Leyfman
Publikováno v:
Cancer Cell International, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Chimeric antigen receptors (CARs) represent a novel facet of modern day synthetic biology that exemplifies personalized medicine at work through their ability to harness and redirect a patient’s immune system to fight cancer. Bo
Externí odkaz:
https://doaj.org/article/1842eee51b8e4364a0614dfb38a0674f
Autor:
Yan Leyfman, Greta Gohring, Muskan Joshi, Gayathri Pramil Menon, Alexandra Van de Kieft, Tania del Rivero, Michael A. Bellio, Maria Ines Mitrani
Publikováno v:
Molecular Therapy. 31:1196-1200
Autor:
Rahul Banerjee, Samuel A. Kareff, Yan Leyfman, Natasha Dhawan, Lindsay R. Hammons, Aakash Desai, Mazie Tsang, Ana I. Velazquez, Amanda Nizam
Publikováno v:
Cancer Investigation. :1-9
Autor:
Anusha Chidharla, Audun Utengen, Deanna J. Attai, Emily K. Drake, G.J. van Londen, Ishwaria M. Subbiah, Elizabeth Henry, Martina Murphy, Maura M. Barry, Rami Manochakian, Scott Moerdler, Stacy Loeb, Stephanie L. Graff, Yan Leyfman, Michael A. Thompson, Merry J. Markham
Publikováno v:
JCO oncology practice. 18(8)
The use of social media continues to increase in health care and academia. Health care practice, particularly the oncologic field, is constantly changing because of new knowledge, evidence-based research, clinical trials, and government policies. The
Autor:
Katherine A. Thornton, Elizabeth H. Baldini, Robert G. Maki, Brian O'Sullivan, Yan Leyfman, Chandrajit P. Raut
Publikováno v:
Holland‐Frei Cancer Medicine. :1-28
Publikováno v:
Surgical Oncology Clinics of North America. 31:381-397
Publikováno v:
Blood. 140:11997-11998
Autor:
Yan Leyfman, Shubhadarshini G. Pawar, William B. Wilkerson, Muskan Joshi, Chandler Howard Park
Publikováno v:
Blood. 140:13097-13098